Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:COUR - US22266M1045 - Common Stock

8.08 USD
-0.13 (-1.58%)
Last: 12/12/2025, 8:22:43 PM
8.07 USD
-0.01 (-0.12%)
After Hours: 12/12/2025, 8:22:43 PM
Fundamental Rating

5

Overall COUR gets a fundamental rating of 5 out of 10. We evaluated COUR against 77 industry peers in the Diversified Consumer Services industry. While COUR has a great health rating, there are worries on its profitability. COUR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
In the past year COUR had a positive cash flow from operations.
COUR had negative earnings in each of the past 5 years.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

COUR has a Return On Assets (-4.60%) which is comparable to the rest of the industry.
COUR has a Return On Equity (-7.16%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR's Gross Margin of 54.36% is fine compared to the rest of the industry. COUR outperforms 64.47% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
COUR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.20. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR has a Altman-Z score of 2.20. This is in the better half of the industry: COUR outperforms 61.84% of its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.2
ROIC/WACCN/A
WACC8.83%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.57. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
COUR has a Current ratio of 2.57. This is amongst the best in the industry. COUR outperforms 81.58% of its industry peers.
COUR has a Quick Ratio of 2.57. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
COUR's Quick ratio of 2.57 is amongst the best of the industry. COUR outperforms 81.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.25% over the past year.
COUR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.10%.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 30.38% on average per year.
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%

3.2 Future

COUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.08% yearly.
COUR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.05% yearly.
EPS Next Y17.21%
EPS Next 2Y15.63%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

4

4. Valuation

4.1 Price/Earnings Ratio

COUR is valuated rather expensively with a Price/Earnings ratio of 19.24.
Compared to the rest of the industry, the Price/Earnings ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 64.47% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of COUR to the average of the S&P500 Index (26.56), we can say COUR is valued slightly cheaper.
A Price/Forward Earnings ratio of 17.77 indicates a rather expensive valuation of COUR.
64.47% of the companies in the same industry are more expensive than COUR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.79. COUR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.24
Fwd PE 17.77
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.3
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 18.08% in the coming years.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y15.63%
EPS Next 3Y18.08%

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield 0%

COURSERA INC

NYSE:COUR (12/12/2025, 8:22:43 PM)

After market: 8.07 -0.01 (-0.12%)

8.08

-0.13 (-1.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-23 2025-10-23/amc
Earnings (Next)01-28 2026-01-28/amc
Inst Owners81.52%
Inst Owner Change5.47%
Ins Owners6.07%
Ins Owner Change-0.95%
Market Cap1.34B
Revenue(TTM)739.78M
Net Income(TTM)-45.81M
Analysts74.29
Price Target12.67 (56.81%)
Short Float %5.16%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.72%
Min EPS beat(2)17.31%
Max EPS beat(2)36.12%
EPS beat(4)4
Avg EPS beat(4)48.89%
Min EPS beat(4)17.31%
Max EPS beat(4)92.38%
EPS beat(8)8
Avg EPS beat(8)1321.29%
EPS beat(12)12
Avg EPS beat(12)907.86%
EPS beat(16)14
Avg EPS beat(16)684.01%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.03%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.04%
Revenue beat(12)9
Avg Revenue beat(12)0.94%
Revenue beat(16)12
Avg Revenue beat(16)0.73%
PT rev (1m)0%
PT rev (3m)1.36%
EPS NQ rev (1m)-3.52%
EPS NQ rev (3m)-14.58%
EPS NY rev (1m)0%
EPS NY rev (3m)1.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 19.24
Fwd PE 17.77
P/S 1.82
P/FCF 15.3
P/OCF 11.01
P/B 2.1
P/tB 2.19
EV/EBITDA N/A
EPS(TTM)0.42
EY5.2%
EPS(NY)0.45
Fwd EY5.63%
FCF(TTM)0.53
FCFY6.54%
OCF(TTM)0.73
OCFY9.08%
SpS4.45
BVpS3.84
TBVpS3.69
PEG (NY)1.12
PEG (5Y)N/A
Graham Number6.03
Profitability
Industry RankSector Rank
ROA -4.6%
ROE -7.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.36%
FCFM 11.88%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 121.61%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 2.2
F-Score5
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y17.21%
EPS Next 2Y15.63%
EPS Next 3Y18.08%
EPS Next 5YN/A
Revenue 1Y (TTM)8.1%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%10.29%
Revenue Next Year8.72%
Revenue Next 2Y7.35%
Revenue Next 3Y7.05%
Revenue Next 5YN/A
EBIT growth 1Y34.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year267.75%
EBIT Next 3Y77.9%
EBIT Next 5YN/A
FCF growth 1Y1633.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y866.87%
OCF growth 3Y279.12%
OCF growth 5YN/A

COURSERA INC / COUR FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to COUR.


What is the valuation status for COUR stock?

ChartMill assigns a valuation rating of 4 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


How profitable is COURSERA INC (COUR) stock?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


How financially healthy is COURSERA INC?

The financial health rating of COURSERA INC (COUR) is 8 / 10.